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applied toward early treatment interventions during tooth decay 
and periodontal disease (Cordeiro et al., 2008). While signifi-
cant progress has been made in the field of bone regeneration 
(Kimelman et al., 2007), stem-cell-mediated bioengineering 
strategies for dentin regeneration present several challenges. For 
example, it has been difficult to recapitulate the developmental 
mechanisms that drive the terminal differentiation of odonto-
blasts, a specialized group of cells that form dentin extracellular 
matrix in a highly vectorial and unidirectional manner. During 
primary dentin formation, odontoblasts retreat from the min-
eralization front, leaving behind cellular processes that remain 
trapped in dentinal tubules (D’Souza and Qin, 2010). Clearly, 
regenerating a functional dentin matrix that more closely resem-
bles the tubular matrix of primary dentin will better impart prop-
erties of permeability and vitality to the restored tooth.
Advances made in the field of bone regeneration contribute 
useful information that can be extrapolated to studies on dentin 
regeneration (Cancedda et al., 2007; Kimelman et al., 2007). 
The use of allogeneic bone matrix showed inconsistent osteo-
genic activity, while therapy with recombinant bone morpho-
genetic proteins (rBMPs) resulted in variables like the lack of 
a sustained delivery and a short half-life that are truly difficult 
to modulate (Franceschi et al., 2004). Hence, ex vivo gene 
therapy, in which cells are made to express the growth factor 
or morphogen of choice, has helped overcome the deficiencies 
of protein therapy by allowing for the sustained delivery of 
inductive molecules to specific target sites (Lieberman et al., 
1999; Cheng et al., 2001). As a next step in advancing the use 
of stem cells for bone regeneration, it was recognized that 
culture conditions cannot provide all the permissive signals 
needed to trigger terminal events in differentiation. Hence, 
approaches of transducing marrow stromal cells with Runx2, a 
transcription factor that is critical for osteoblast differentia-
tion, resulted in substantially more bone and enhanced healing 
of a critical-sized cranial defect in mice (Zhao et al., 2007). 
Advances in skeletal biology research revealed another layer 
of complexity when studies revealed that Runx2’s role in 
osteoblast differentiation was controlled by its protein partner, 
Twist1. Relief of the functional antagonism between Runx2 
and Twist1 causes the onset of osteoblast differentiation, as 
marked by the appearance of genes that mark a commitment to 
mineralization (Bialek et al., 2004). The precise relationship of 
Runx2 and Twist1 during odontoblast differentiation is not 
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Stem cells derived from the dental pulp of extracted human third 
molars (DPSCs) have the potential to differentiate into odonto-
blasts, osteoblasts, adipocytes, and neural cells when provided 
with the appropriate conditions. To advance the use of DPSCs 
for dentin regeneration, it is important to replicate the permis-
sive signals that drive terminal events in odontoblast differentia-
tion during tooth development. Such a strategy is likely to 
restore a dentin matrix that more resembles the tubular nature of 
primary dentin. Due to the limitations of culture conditions, the 
use of ex vivo gene therapy to drive the terminal differentiation 
of mineralizing cells holds considerable promise. In these stud-
ies, we asked whether the forced expression of TWIST1 in 
DPSCs could alter the potential of these cells to differentiate 
into odontoblast-like cells. Since the partnership between Runx2 
and Twist1 proteins is known to control the onset of osteoblast 
terminal differentiation, we hypothesized that these genes act to 
control lineage determination of DPSCs. For the first time, our 
results showed that Twist1 overexpression in DPSCs enhanced 
the expression of DSPP, a gene that marks odontoblast terminal 
differentiation. Furthermore, co-transfection assays showed that 
Twist1 stimulates Dspp promoter activity by antagonizing 
Runx2 function in 293FT cells. Analysis of our in vitro data, 
taken together, suggests that lineage specification of DPSCs can 
be modulated through ex vivo gene modifications.
When compared with the engineering of an entire biologic tooth, the targeted regeneration of individual tissues, such 
as dentin and bone, offers a more practical alternative that can be 
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known. Such an understanding is important for translation to 
applications for dentin-specific tissue regeneration.
The availability of tooth-derived stem cell populations has 
opened up new and exciting avenues for the use of cell-mediated 
approaches for dentin regeneration (Gronthos et al., 2000; Zhang 
et al., 2006; Sloan and Smith, 2007; Cordeiro et al., 2008). The 
first pulp-derived stem cell population was isolated from impacted 
adult wisdom teeth and was termed “DPSC” (dental pulp stem 
cells) (Gronthos et al., 2000). Three years later, stem cells were 
harvested from human exfoliated deciduous teeth (SHED) (Miura 
et al., 2003). Both cell lines are clonogenic, form adherent cell 
clusters, and are capable of multilineage differentiation (Gronthos 
et al., 2000; Miura et al., 2003). Interestingly, SHED and DPSC 
can be maintained after cryopreservation (Zhang et al., 2006) and 
hence provide a valuable and reliable tool for tissue engineering. 
SHED and DPSC express mineralization markers and form min-
eralization nodules after culture in the presence of inductive 
media containing ascorbic acid, dexamethasone, and inorganic 
phosphate (Gronthos et al., 2000; Miura et al., 2003; Gay et al., 
2007; Wei et al., 2007; Yang et al., 2007). After transplantation
in vivo, increased population doublings were observed for SHED 
that appeared more immature and highly proliferative when com-
pared with DPSC (Gronthos et al., 2000; Miura et al., 2003). Our 
previous work on SHED and DPSC in peptide amphiphile hydro-
gels confirmed these observations and revealed further differ-
ences. SHED maintain their high proliferation rates and a 
spindle-shaped, fibroblast-like morphology. They produce large 
amounts of collagen and thus form coherent soft tissues during a 
four-week culture period. DPSC growth is significantly slower in 
the three-dimensional environment. Up-regulation of marker 
genes of differentiated osteoblasts/odontoblasts and a higher 
potential for mineral deposition indicate that DPSC can be driven 
further toward terminal differentiation (Galler et al., 2008). 
Whether the modulation of gene expression in odontoblast pro-
genitors mimics odontoblast differentiation during tooth develop-
ment has yet to be determined. These studies were specifically 
designed to assess the roles of TWIST1 in driving the potential of 
DPSCs to differentiate into odontoblasts by lentiviral methods of 
gene transfer.
MAterIALs & MethODs
Plasmid construction
The human TWIST1 cDNA (Open Biosystem, Rockford, IL, 
USA) was subcloned into the EcoRI and HincII sites of the 
pWPI lentiviral vector (Addgene, Cambridge, MA, USA). The 
empty pWPI vector, encoding enhanced green fluorescent pro-
tein (EGFP), was used as the control. Two TWIST1 silencing 
vectors, expressing different short hairpin RNA (shRNAmir) 
sequences targeting different segments of human TWIST1 
mRNA, were obtained from Open Biosystem. The silencing 
effects of each shRNA on the target gene were determined by 
Western blot analysis of target protein expression following 
infection of DPSC cells with shRNA-expressing lentiviruses 
(see below). The shRNA sequence yielding the highest suppres-
sion level against the target gene was used for following studies. 
The empty pGIPZ silencing vector, expressing Turbo green 
fluorescent protein (tGFP), from Open Biosystem, was used as 
control.
To generate the pDspp-luc construct, we released a 5.7-kb 
promoter fragment of Dspp gene from the pBS II SK+ vector 
(provided by Dr. Ashok Kulkarni, NIH/NIDCR) by XbaI and 
NruI digestion and subcloned it into the NheI and HindIII sites 
of the pGL3-basic vector (Promega, Madison, WI, USA). The 
pDmp1-luc construct, containing a 9.6-kb promoter region, 
exon 1 and intron 1 of the Dmp1 gene, was prepared as 
described earlier (Lu et al., 2005). The human RUNX2 cDNA, 
encoding FLAG-RUNX2, was obtained from Dr. Brendan Lee.
culture of DPscs
DPSCs isolated from adult human third molars were kindly 
provided by Dr. Songtao Shi at the University of Southern 
California. DPSCs were maintained in growth medium, contain-
ing alpha modification of Eagle’s medium (Invitrogen, Carlsbad, 
CA, USA) supplemented with 15% fetal calf serum (Hyclone, 
Logan, UT, USA), 100 µg/mL L-ascorbic acid 2-phosphate 
(Sigma, St. Louis, MO, USA), 2 mmol/L glutamine (Invitrogen), 
100 IU/mL penicillin, and 100 µg/mL streptomycin (Invitrogen). 
For differentiation assays, DPSCs were grown to confluence in 
growth medium, then in differentiation medium containing nor-
mal growth medium supplemented with 100 µg/mL L-ascorbic 
acid 2-phosphate, 2 mM β-glycerophosphate, and 10 nM dexa-
methasone for 2 or 4 wks.
Lentivirus Packaging
293FT cells (Invitrogen) were maintained in DMEM supplemented 
with 10% fetal bovine serum (Hyclone), 2 mmol/L glutamine 
(Invitrogen), 100 IU/mL penicillin, and 100 µg/mL streptomycin 
(Invitrogen). To prepare lentivirus for DPSC cell infection, we co-
transfected 293FT cells with lentiviral vector, packaging vector 
psPAX2, and envelope vector pMD2.G, using Fugene6 (Roche, 
Indianapolis, IN, USA), as per the manufacturer’s instructions. The 
supernatant was collected 48 hrs after transfection and filtered with 
0.45-µm filters for removal of cell debris.
Lentiviral transduction and cell-sorting
For lentiviral transduction, sub-confluent DPSCs were incubated 
with lentiviral supernatant in the presence of 10 µg/mL of poly-
brene (Sigma) for 48 hrs, with lentiviral supernatant changed once. 
DPSCs stably expressing green fluorescent protein (GFP) were 
selected by fluorescent-activated cell-sorting (FACS), with the use 
of a Vantage SE Diva cell sorter (Becton Dickinson, Franklin 
Lakes, NJ, USA). Sorted DPSCs were expanded for two passages 
for further studies. Cells over expressing or silencing TWIST1 were 
confirmed by Western blot analysis.
Western blot Analysis and von Kossa staining
Blots were first immunolabeled with the following primary anti-
bodies, anti-TWIST1 monoclonal antibody (Abcam, 1:50), anti-
alkaline phosphatase monoclonal antibody (Abcam, Cambridge, 
MA, USA; 1:100), anti-osteocalcin monoclonal antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA; 1:1000), rabbit 
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anti-dentin matrix protein 1 polyclonal antibody (gift from Larry 
W. Fisher, 1:500), anti-osteopontin monoclonal antibody (Santa 
Cruz Biotechnology, 1:1000), rabbit anti-dentin sialoprotein poly-
clonal antibody (gift from Larry W. Fisher, 1:250), or anti-β-actin 
monoclonal antibody (Sigma, 1:20,000). They were then incu-
bated with horseradish-peroxidase-conjugated goat anti-mouse or 
anti-rabbit secondary antibody (Santa Cruz Biotechnology). The 
blot was finally detected with ECL reagents (GE Healthcare Bio-
Sciences, Piscataway, NJ, USA).
For von Kossa staining, DPSC cells were fixed with 4% 
paraformaldehyde-0.1M phosphate buffer, and stained with 
10% silver nitrate for von Kossa staining.
Promoter-luciferase Assays
We used promoter-luciferase assays to determine the effects of 
RUNX2 and TWIST1 interactions on Dmp1 and Dspp promoter 
activities in 293FT cells. The cells were transiently transfected 
with pDmp1-Luc or pDspp reporter construct and empty vector 
or vectors expressing FLAG-RUNX2 or TWIST1 or both, with 
Fugene 6 as described above. pRL-TK was co-transfected as an 
internal control for normalizing transfection efficiency. Firefly 
and Renilla luciferase activities were analyzed 48 hrs after trans-
fection with the use of a dual luciferase assay system (Promega) 
following the manufacturer’s instructions. Each assay was per-
formed in triplicate and repeated at least three times.
resuLts
tWIst1 enhances the Odontoblast-like  
Differentiation of DPscs
We first assessed whether the transduction of dental stem cells 
with transcription factors like TWIST1 would alter their differen-
tiation into osteoblasts and odontoblasts. DPSCs that were stably 
transduced with lentivirus expressing TWIST1 or their silencing 
RNA probe or control vector were carefully selected by cell-
sorting. Western blot analysis showed that the overexpression of 
TWIST1 in DPSCs stably transduced with TWIST1 lentiviral 
vectors (Fig. 1A). The TWIST1 silencing lentiviral vectors, ShT1 
and ShT2, reduced the levels of TWIST1 protein 50% and 90%, 
respectively (Fig. 1B). Therefore, ShT2 were selected for subse-
quent TWIST1 silencing experiments.
Next, we analyzed the effects of Twist1 overexpression and 
silencing on the differentiation potential of DPSCs, including 
differentiation markers and mineral deposition. The differentia-
tion markers analyzed for both osteoblasts and odontoblasts 
include an early-differentiation marker, alkaline phosphatase 
(ALP), and 4 late-differentiation markers, osteocalcin (OCN), 
dentin matrix protein 1 (DMP1), osteopontin (OPN), and dentin 
sialophosphoprotein (DSPP). Western blot analysis showed that 
TWIST1 overexpression enhanced the expression of OCN, 
DMP1, and OPN as well as DSP, but had no apparent effect on 
ALP expression (Fig. 1C, left panel). Consistently, TWIST1 
silencing dramatically enhanced the expression of ALP, but had 
differential effects on the late-differentiation markers, inhibiting 
DMP1, OPN, and DSP expression while exerting no effect on 
OCN expression (Fig. 1C, right panel). Consistent with the 
Western blot data, von Kossa staining showed that TWIST1 
overexpression enhanced the mineral deposition of DPSCs, 
whereas its silencing appeared to inhibit mineralization 
(Fig. 2A). DSPP is an odontoblast-specific differentiation 
marker, which is processed into N-terminal fragment, DSP, and 
Figure 1. TWIST1 modulates the odontoblast-like differentiation of 
human DPSCs. (A) Human DPSCs were stably transduced with len-
tiviruses expressing TWIST1 (LV-TWIST1) or empty lentiviral vectors 
expressing only enhanced green fluorescent protein (LV-EGFP). Western 
blot analysis showed the overexpression of Twist1 in DPSCs trans-
duced with LV-TWIST1 compared with LV-EGFP. (b) Human DPSCs were 
transduced with lentiviruses expressing 2 short hairpin RNA targeting 
human TWIST1 mRNA (LV-ShT1 or LV-ShT2, respectively) or empty lenti-
viral vectors expressing only Turbo green fluorescent protein (LV-TGFP). 
Western blot analysis showed that LV-ShT1 and LV-ShT2 knocked down 
TWIST1 expression by 50% and 90%, respectively. (c) Western blot 
analysis of total proteins extracted from DPSCs stably transduced with 
TWIST1 overexpressing (LV-TWIST1, left panel) or silencing (LV-ShT2, 
right panel) lentiviral vectors or their control vectors. DPSCs stably 
transduced with the indicated lentiviral vectors were allowed to grow 
for 2 wks in the differentiation medium. Total proteins were extracted 
and analyzed with antibodies for ALP, OCN, DMP1, OPN, and DSP, 
with β-actin as a loading control. TWIST1 overexpression enhanced 
the expression of OCN, DMP1, and OPN as well as DSP, but had no 
apparent effect on ALP expression. Consistently, TWIST1 silencing dra-
matically enhanced the expression of ALP, but inhibited DMP1, OPN, 
and DSP, and had no effect on OCN expression.
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C-terminal fragment, DPP after synthesis. Analysis of these 
data thus suggests that TWIST1 enhances the mineralizing 
capacity of DPSCs, most likely through promoting the expres-
sion of DSPP, a late-differentiation maker of odontoblast 
differentiation.
tWIst1 stimulates Dmp1 and Dspp Promoter Activities
Previous studies have shown that Twist1 inhibits the transactiva-
tion functions of Runx2 by binding to its DNA-binding domain. 
It is the release of this functional antagonism between Twist1 
and Runx2 that triggers the onset of osteoblast differentiation 
(Bialek et al., 2004). To determine the effects of TWIST1 and 
RUNX2 protein interaction on odontoblast differentiation, we 
studied the functional consequences of their interactions on the 
promoter activities of 2 odontoblast differentiation markers, 
Dmp1 and Dspp. pDspp-Luc or pDmp1-Luc were transiently 
co-transfected into 293FT cells with expression vectors for 
FLAG-RUNX2 or TWIST1 alone or both. Although co-trans-
fection of RUNX2 expression vector increased Dmp1 promoter 
activity by 33%, TWIST1 expression vector resulted in a 3.7-
fold increase in Dmp1 promoter activity (Fig. 2B). More inter-
estingly, co-transfection of RUNX2 expression vector decreased 
Dspp promoter activity by 28%, in contrast to a 2.5-fold 
increase in Dspp promoter activity with TWIST1 (Fig. 2C). 
Further, co-transfection of both RUNX2 and TWIST1 expres-
sion vectors resulted in a 63% decrease in Dmp1 promoter activ-
ity and a 55% decrease in Dspp promoter activity, compared 
with TWIST1 expression vector alone (Figs. 2B, 2C). Analysis 
of these data suggests that TWIST1 activates Dmp1 and Dspp 
promoter activities, and antagonizes the effects of Runx2 func-
tion on these promoters.
DIscussION
In this study, we have demonstrated that the differentiation 
capacity of human-tooth-derived pulpal stem cells, DPSCs, 
could be altered by overexpressing or silencing TWIST1 levels 
with lentiviral vectors. We showed that DPSCs could be stably 
transduced with lentivirus vectors that either increased or 
silenced expression levels of TWIST1. Analyses of these lenti-
virus-transduced DPSCs revealed that TWIST1 has the potential 
to enhance the odontoblastic potential of DPSCs in a manner 
that will benefit the regeneration of dentin.
Lentivirus-mediated TWIST1 overexpression stimulated 
expression of all the late-mineralization markers—OCN, DMP1, 
and OPN—that are common for both osteoblasts and odonto-
blasts. In addition, TWIST1 overexpression also enhanced the 
expression of DSPP, a tooth-specific marker. We thus conclude 
that such transduced DPSCs assumed a phenotype more resem-
bling odontoblasts than osteoblasts. Consistently, lentivirus-
mediated Twist1 silencing reduced DSPP protein expression. 
Furthermore, analysis of data from co-transfection assays con-
firmed that TWIST1 directly activates the Dspp promoter, and 
that this activity is significantly reduced in the presence 
of RUNX2. Similar effects of TWIST1 activation of Dmp1 
were observed in the presence and absence of RUNX2. These 
Figure 2. TWIST1 regulates mineralization of DPSCs through antago-
nizing RUNX2 function. (A) Von Kossa staining. DPSCs stably trans-
duced with the indicated lentiviral vectors were cultured for 4 wks in the 
differentiation medium. Mineralization was determined by von Kossa 
staining. TWIST1 overexpressing enhanced the mineral deposition 
of DPSCs (LV-TWIST1, left panel), whereas its silencing inhibited the 
mineral deposition (LV-ShT2, right panel). (b) pDmp1-Luc reporter con-
struct was transiently co-transfected into 293FT cells with expression 
vectors for RUNX2 or TWIST1 alone or both. While RUNX2 stimulated 
Dmp1 promoter activity, it inhibited the stimulatory effects of TWIST1 
on Dmp1 promoter activity. Data are mean ± the standard error of 
mean (SEM), n = 3. (c) pDspp-Luc reporter construct was transiently 
co-transfected into 293FT cells with expression vectors for RUNX2 or 
TWIST1 alone or both. RUNX2 inhibited Dspp promoter activity, and 
further inhibited the stimulatory effects of TWIST1 on Dspp promoter 
activity. Data are mean ± SEM, n = 3.
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observations can be interpreted to suggest that the partnership 
between RUNX2 and TWIST1 is important for the diversifica-
tion of odontoblasts from osteoblasts, and that TWIST1 may be 
responsible for driving terminal differentiation of odontoblasts 
through its activation of Dspp expression.
These data closely align with information derived from 
developmental studies. During tooth development, Runx2 and 
Twist1 share overlapping yet unique profiles of expression in 
dental mesenchyme. Both genes are co-expressed during tooth 
initiation and morphogenesis (bud, cap, and early bell stages). 
Interestingly, at the onset of odontoblast differentiation, Runx2 
is markedly down-regulated (D’Souza et al., 1999), while 
Twist1 expression persists in the cells that lie at the interface 
with dental epithelium and are destined to become odontoblasts 
(Bourgeois et al., 1998). This is in sharp contrast to expression 
profiles of Runx2 and Twist1 within the osteogenic zones that 
are contiguous with dental mesenchyme. Runx2 expression 
persists in osteoblasts that differentiate and form osteoid at the 
time that Twist1 expression is markedly down-regulated. These 
differential profiles of expression of Runx2 and Twist1 during 
odontoblast and osteoblast differentiation suggest that further 
lineage determination of mineralizing cells is the result of differ-
ences in signaling pathways that control gene expression in 
odontogenic vs. osteogenic zones. Our earlier studies also 
showed that the up-regulation of the odontoblast differentiation 
markers, type I collagen and Dspp, occurred only after Runx2 
expression decreased, and was closely correlated to the persis-
tence of Twist1 expression in the pre-odontoblast layer (D’Souza 
et al., 1999; Galler et al., 2008). Furthermore, previous studies 
have demonstrated that continuous Runx2 expression inhibits 
the terminal differentiation of odontoblasts, resulting in their 
transdifferentiation into osteoblasts, as marked by the loss of 
Dspp gene expression (Miyazaki et al., 2008). The observation 
that Twist1 overexpression did not affect ALP levels indicates 
that genes that mark the earliest commitment to mineralization 
are not involved. These expression profiles suggest that Runx2 
and Twist1 may partner in tooth development at stages that pre-
cede cell differentiation and matrix synthesis. However, it is 
Twist1 that is likely needed for the terminal events that drive 
odontoblast differentiation and the subsequent deposition of 
primary dentin matrix.
The present in vitro studies, although limited in approach, 
will provide a framework for future studies that should test the 
ability of Twist1 expressing cells to form dentin matrix both 
in vitro and in vivo. Clearly, ex vivo gene therapy methods may 
not offer the most practical alternative for enhancing the tar-
geted differentiation of dental stem cells in tissue-engineering 
strategies for dentin regeneration. However, these studies pro-
vide the impetus for future experiments that will identify effec-
tor molecules of Twist1 that could be used therapeutically.
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